SamSearch Platform
AI-powered intelligence for the right opportunities, the right leads, and the right time.
Contract Category
2 federal contract opportunities classified as Injection Vials.
AI Summary
The National Institutes of Health intends to negotiate a sole source acquisition for X10 vials of Floxuridine 500MG for patient care. This is not a request for proposal, but interested vendors may submit capability statements by June 3, 2026. The acquisition is justified under FAR 6.302-1, citing only one responsible s…
MD
AI Summary
The National Institutes of Health intends to award a sole source contract to Cardinal Health for the purchase of X11 vials of Floxuridine 500MG for patient care. This acquisition is conducted under FAR Part 13 Simplified Acquisition Procedures, and interested parties may submit their capabilities by March 5, 2026.
MD
Common questions about finding and winning Injection Vials government contracts.